‘Turning point’ in the fight against Alzheimer’s as drug found to slow disease The results of a new trial were labelled as symbolic of ‘a new era where Alzheimer’s disease could become treatable’ The Independent UK · Jul 17, 2023
‘Turning point in the fight against Alzheimer’s’ as drug found to slow disease Donanemab has been found to slow down the disease in a clinical trial. The Independent UK · Jul 17, 2023
Young-onset Alzheimer’s can be diagnosed from as early as 30 – and the symptoms are often different Alzheimer’s disease is often thought of as a condition that only affects the elderly. But around 3.9 million people worldwide aged 30-64 live with young-onset Alzheimer’s disease – a form of dementia in which symptoms appear before the age of 65. The Conversation · Jul 13, 2023
Sanders: Alzheimer's drug too expensive "The high price of Leqembi threaten Medicare's finances, it will also negatively impact seniors on fixed incomes" Salon · Jul 12, 2023
FDA fully approves new Alzheimer’s drug to slow down disease progression ‘Today’s action is first verification that a drug targeting underlying disease process has shown clinical benefit’ The Independent UK · Jul 7, 2023
Fiona Phillips ‘hugely touched’ by support after revealing Alzheimer’s diagnosis The former GMTV anchor announced she was diagnosed more than a year ago with the condition Evening Standard · Jul 5, 2023
Is Alzheimer's disease hereditary? What are your chances of getting Alzheimer's disease if your parents had it There are certain gene changes that can increase your likelihood of getting the disease Wales Online · Jul 5, 2023
What are the symptoms of Alzheimer’s? New medication donanemab found to slow mental decline Scientists believe that Alzheimer’s is triggered because of an abnormal build-up of proteins in the brain Evening Standard · Jul 5, 2023
Early signs of Alzheimer's and when to see a GP as Fiona Phillips diagnosed The TV presenter has gone public about her diagnosis Wales Online · Jul 5, 2023
The form of exercise that can help prevent Alzheimer’s disease, according to new study Experiments with genetically modified mice reveal form of exercise that can help prevent condition The Independent UK · Jul 4, 2023
Exercising Regularly May Help Prevent Alzheimer’s Regular gym work-outs could stave off Alzheimer's, say scientists Zenger · Jun 30, 2023
Higher levels of lean muscle might protect against Alzheimer’s disease – study Further research is needed to investigate the clinical and public health implications of the findings. The Independent UK · Jun 29, 2023
Extra benefits of intermittent fasting "Intermittent fasting has been shown to have various health benefits [including] the promotion of brain health" Salon · Jun 29, 2023
Intermittent fasting could help protect the brain from age-related diseases like Alzheimer's As the world population has grown older, Alzheimer’s disease has become increasingly common. Alzheimer’s disease is the most prevalent form of dementia. Dementia is a term used to describe a range of symptoms linked to the decline in brain function with age. Symptoms include memory loss, communication difficulties, problem-solving struggles,… The Conversation · Jun 29, 2023
StockNews.com · Jun 27, 2023 3 Stocks to Own as Alzheimer's Drugs Bring Relief The number of people with dementia, including those with Alzheimer's disease, are projected to increase from 50+ million now to more than 150 million in 2050, according to Alzheimer's Disease International. Those sheer numbers will mean that investors in certain stocks, producing Alzheimer's drugs to combat the disease, are poised…
Fortune · Jun 23, 2023 Are you at risk of developing Alzheimer's Disease? A simple screener can tell—and so can these 11 early warning signs A quick test that mimics real-life phone tasks can tell if a senior is at risk for Alzheimer’s disease, according to a new study.
The Independent UK · May 23, 2023 LOCALIZE IT: From birth to death, Black Americans struggle with health care system EDITORS/NEWS DIRECTORS:
Wales Online · May 18, 2023 All you need to know about weight-loss drug Wegovy and Ozempic tipped to treat dementia Although age is by far the greatest risk factor for dementia, obesity and type 2 diabetes are also major risk factors
The Conversation · May 18, 2023 Wegovy and Ozempic: could the new weight-loss drug also treat dementia? Over 55 million people worldwide have dementia. This mind-robbing condition has a huge impact on society and the economy, so scientists are working hard to find ways to treat or prevent it. One of the avenues being explored is the new weight-loss jab, Wegovy.
Wales Online · May 16, 2023 Scientists make Alzheimer's breakthrough thanks to man who could hold cure in his genes Rare genetic resilience to the disease has been identified in a second patient
Inverse · May 16, 2023 Scientists Discover New Genetic Variants That Protect Against Alzheimer’s Disease In a new study, researchers identified a rare gene mutation that may offer resiliency against Alzheimer's disease.
The Independent UK · May 15, 2023 Researchers identify rare genetic resilience to Alzheimer’s disease – study Researchers suggest the findings could open a door for the prevention and treatment of incurable diseases.
Dynamite News · May 14, 2023 Study reveals traffic-related air pollution affects brain function According to a study from the University of California, Irvine, exposure to traffic-related air pollution causes memory loss, cognitive decline, and the activation of brain pathways linked to the onset of Alzheimer's disease. Read further on Dynamite News:
Wales Online · May 11, 2023 All you need to know about 'promising' new Alzheimer's drug Donanemab was shown in a late-stage trial to slow cognitive decline more than a third
The Conversation · May 9, 2023 New Alzheimer’s drug: what you need to know about donanemab’s promising trial results American pharmaceutical company Eli Lilly announced last week that it had seen encouraging clinical trial results of its new Alzheimer’s medication. According to the company, their experimental drug, donanemab, was shown in a late-stage trial to slow cognitive decline by 35%. While these results do sound promising, the full data…